Detailed Information on Publication Record
2019
Efficient and robust preparation of tyrosine phosphorylated intrinsically disordered proteins
BRÁZDA, Pavel, Ondrej ŠEDO, Karel KUBÍČEK and Richard ŠTEFLBasic information
Original name
Efficient and robust preparation of tyrosine phosphorylated intrinsically disordered proteins
Authors
BRÁZDA, Pavel (203 Czech Republic, belonging to the institution), Ondrej ŠEDO (203 Czech Republic, belonging to the institution), Karel KUBÍČEK (203 Czech Republic, belonging to the institution) and Richard ŠTEFL (203 Czech Republic, guarantor, belonging to the institution)
Edition
BioTechniques, UNITED HOUSE, 2 ALBERT PL, LONDON N3 1QB, FUTURE SCI LTD, 2019, 0736-6205
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.541
RIV identification code
RIV/00216224:14740/19:00107820
Organization unit
Central European Institute of Technology
UT WoS
000475967900005
Keywords in English
C-terminal domain; co-expression; CTD; IDP; intrinsically disordered proteins; phosphorylation; purification; RNA polymerase II; TRANSCRIPTION TERMINATION; LARGEST SUBUNIT; CELL-CYCLE; KINASE; STRATEGIES; SEMISYNTHESIS
Tags
International impact, Reviewed
Změněno: 14/10/2024 13:09, Ing. Jana Kuchtová
Abstract
V originále
Intrinsically disordered proteins (IDPs) are subject to post-translational modifications. This allows the same polypeptide to undertake different interaction networks with different consequences, ranging from regulatory signalling networks to formation of membraneless organelles. We report a robust method for co-expression of modification enzyme and SUMO-tagged IDP with subsequent purification procedure allowing production of modified IDP. The robustness of our protocol is demonstrated on a challenging system, RNA polymerase II C-terminal domain (CM), that is a low-complexity repetitive region with multiple phosphorylation sites. In vitro phosphorylation approaches fail to yield multiple-site phosphorylated CTD, whereas our in vivo protocol allows to rapidly produce near homogeneous phosphorylated CTD at a low cost. These samples can be used in functional and structural studies.
Links
GA15-17670S, research and development project |
| ||
GA18-11397S, research and development project |
| ||
LQ1601, research and development project |
| ||
649030, interní kód MU |
| ||
90043, large research infrastructures |
|